Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Open-market buy Chief Executive Officer bought 7,500 shares at $8.11 ($60,825)
  2. 4 Open-market buy 10% owner bought 25,000 shares at $8.03 ($200,735)
  3. 4 Shares withheld for taxes Chief Commercial Officer gave up 9,778 shares (to pay taxes)
  4. 4 Open-market buy 10% owner bought 20,000 shares at an average $14.60 ($292,076)
  5. 4 Open-market buy Chief Executive Officer bought 5,800 shares at $17.05 ($98,890)
  6. 4 Open-market buy Director bought 20,000 shares at $16.92 ($338,400)
  7. 4 Shares withheld for taxes Chief Executive Officer gave up 299,968 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Commercial Officer gave up 109,080 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Financial Officer gave up 136,350 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Shares withheld for taxes Chief Executive Officer gave up 117,633 shares (to pay taxes)
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 34,442 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Financial Officer gave up 9,602 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Executive Officer gave up 35,179 shares (to pay taxes)
  19. 4 Open-market buy Chief Executive Officer bought 25,000 shares at $13.39 ($334,750)
  20. 4 Open-market buy Chief Financial Officer bought 2,500 shares at $13.54 ($33,850)

Page 4 of 15 · 296 filings